
CSL Seqirus Lands Major Canadian Pandemic Vaccine Deal, Upgrades to Cell-Based Production
CSL Seqirus secures new pandemic preparedness contract with Canada's health agency, replacing egg-based vaccines with advanced cell-based technology for rapid production.
CSLLYpandemic preparednessinfluenza vaccine